Abstract:Jingchen Hao, 1, &ast Zhangrui Zeng, 1, &ast Xue Xiao, 2 Yinhuan Ding, 1 Jiamin Deng, 3 Yueshuai Wei, 1 Jinbo Liu 1 1 Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China; 2 Department of Laboratory Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jinbo Liu, Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China, Tel/Fax +86 830 3165730, Email Background: Colistin is one of the few options for treating carbapenem-resistant Enterobacterales (CREs). There is little available information about the epidemic status of colistin-resistant CREs in Southern Sichuan, China. This study mainly investigated the genomic and phenotypic characteristics of an extensively drug resistant E. coli LZ00114 isolated from Luzhou, China. Materials and Methods: In 2020, LZ00114 was isolated from the urine of a patient with hydronephrosis and urinary tract infection in Luzhou, China. We assessed the resistance profile of LZ00114 in the presence and absence of the protonophore carbonyl cyano-m-chlorophenylhydrazine (CCCP) and 1-(1-naphthylmethyl)-piperazine (NMP) by antimicrobial susceptibility testing. The growth kinetics, motility, and pathogenicity of LZ00114 were determined to evaluate its microbial characteristics. In combination with whole genome sequencing (WGS) and real-time reverse transcription PCR (RT-PCR), we comprehensively analyzed the resistance mechanisms of LZ00114. Results: LZ00114 was resistant to various antimicrobial agents, including meropenem, tetracycline, ciprofloxacin, gentamicin, fosfomycin, and polymyxin B. Notably, CCCP reversed the resistance of LZ00114 to polymyxin B. LZ00114 displayed high pathogenicity in the infection model ( P < 0.01) compared with the Lab-WT strain, and its growth rate and motility were not significantly different from the Lab-WT strain. WGS and conjugation revealed that LZ00114 belonged to ST410 and carried a bla NDM-5 -harboring self-transmissible IncX3 plasmid and a multi-replicon IncFII/FIA/FIB plasmid carrying bla OXA-1 - bla CTX-M-55 - tet(B)-aac(6')-Ib-cr-dfrA17-sul1-fosA3 . Comparative genomics revealed genetic relatedness between LZ00114 and strains isolated from other regions. Furthermore, there were point mutations in pmrA (S29G, G144S), pmrB (D283G, Y358N), marR (G103S, Y137H), emrA (I219V), and emrD (G323D) of LZ00114. RT-PCR confirmed the overexpression of efflux pumps and PmrABC in LZ00114. Conclusion: This study provides valuable information for the surveillance of antimicrobial resistance and a theoretical basis for the prevention and control of colistin-resistant E. coli . There is still a need to be vigilant about the clone spread of the high-risk clone group E. coli ST410. Keywords: E. coli , antimicrobial resistance, whole genome sequencing, colistin, carbonyl cyanide m-chlorophenylhydrazine, CCCP, ST410 Escherichia coli is a common Gram-negative opportunistic pathogen that causes invasive host infections through virulence factors such as flagella, toxin secretion, and adhesins. According to the source of the infection, pathogenic E. coli can be classified as intestinal (diarrheagenic) and extraintestinal (ExPEC). Uropathogenic E. coli (UPEC) is the most common lineage of ExPEC. In hospitals, the likelihood of opportunistic infections is high in immunocompromised patients as well as those needing catheters. 1 These pathogens adhere to the uroepithelium through the synergistic actions of various virulence factors and cause ascending infections of the bladder, kidneys, and blood by regulating the movement of bacterial pili. 2,3 However, the emergence of antimicrobial resistance makes treating these bacterial infections a thorny problem. 4 ST131 was previously considered the central lineage of antimicrobial resistance transmission in extraintestinal E. coli , with ST167 and ST410 gradually emerging as new high-risk clones. 5–7 For these strains, carbapenemase production is the primary mechanism of carbapenem resistance in Enterobacterales. The worldwide epidemic of bla -Abstract Truncated-

Epidemiological Characterization of Colistin and Carbapenem Resistant Enterobacteriaceae in a Tertiary: A Hospital from Anhui Province

Genome Assessment of Carbapenem- and Colistin-Resistant Escherichia Coli from Patients in a Sentinel Hospital in China.

Molecular Epidemiology and Genomic Characterization of a Plasmid-Mediated Mcr-10 and Blandm-1 Co-Harboring Multidrug-Resistant Enterobacter Asburiae.

Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a chinese hospital

Identification of Plasmid-Mediated Carbapenem-Hydrolyzing Β-Lactamase KPC-2 in Enterobacteriaceae

Complete Genomic Characterization of Two Escherichia Coli Lineages Responsible for a Cluster of Carbapenem-Resistant Infections in a Chinese Hospital

High Prevalence of Colistin Resistance and Mcr-9/10 Genes in Enterobacter Spp. in a Tertiary Hospital over a Decade.

Occurrence of Enterobacter hormaechei carrying blaNDM-1 and blaKPC-2 in China.

The Co-Transfer of Plasmid-Borne Colistin-Resistant Genes Mcr-1 and Mcr-3.5, the Carbapenemase Gene Blandm-5 and the 16S Methylase Gene Rmtb from Escherichia Coli

Characterization of a Clinical Enterobacter Hormaechei Strain Belonging to Epidemic Clone ST418 Co-Carrying Blandm-1, Blaimp-4 and Mcr-9.1

Microbiological Characteristics of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates Collected from County Hospitals

Molecular characterization of NDM-1-producing carbapenem-resistant E. cloacae complex from a tertiary hospital in Chongqing, China

Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene Mcr-1 in CRE in a Hospital in Henan, China.

Co-occurrence of dual carbapenemases KPC-2 and OXA-48 with the mobile colistin resistance gene mcr-9.1 in Enterobacter xiangfangensis

Genomic and Phenotypic Characterization of a Colistin-Resistant Escherichia coli Isolate Co-Harboring blaNDM-5, blaOXA-1, and blaCTX-M-55 Isolated from Urine

The Co-occurrence of mcr-3 and fosA3 in IncP plasmid in ST131 Escherichia coli: A novel case

Clinical Distribution Characteristics of 1439 Carbapenem-Resistant Escherichia coli Strains in China: Drug Resistance, Geographical Distribution, Antibiotic MIC50/90

Fecal Carriage And Epidemiology Of Carbapenem-Resistant Enterobacteriaceae Among Hospitalized Patients In A University Hospital

Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant Enterobacterales Isolates in a Teaching Hospital in Guangzhou, China.

High Prevalence of Metallo-β-Lactamase-Producing Enterobacter Cloacae from Three Tertiary Hospitals in China.

Co-occurrence of<i> mcr-3</i> and<i> fosA3</i> in IncP plasmid in ST131<i> Escherichia</i><i> coli:</i> A novel case